PARP1 - poly(ADP-ribose) polymerase 1 Gene
Species: Sus scrofa
Gene Type: protein coding
Gene ID: 100621034
About PARP1
Primary_assembly 10: 14,203,160-14,241,196 reverse strand.Sscrofa11.1:CM000821.5
This gene has 1 transcript (splice variant), 210 orthologues and 2 paralogues. Ubiquitous expression in ovary (RPKM 36.7), spleen (RPKM 24.3) and 8 other tissues.
PARP1 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| XM_003357641.4 | XP_003357689.2 | LOW QUALITY PROTEIN: poly [ADP-ribose] polymerase 1 |
PARP1 Protein Structure
PLN03123
PLN03123: cl33639 (5 - 1013)
- 0
- 200
- 400
- 600
- 800
- 1018 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
LOW QUALITY PROTEIN: poly [ADP-ribose] polymerase 1 |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(17)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-10162 | Olaparib | Inhibitor | 99.98% | Yes |
| HY-16106 | Talazoparib | Inhibitor | 99.89% | Unkown |
| HY-10619 | Niraparib | Inhibitor | 99.96% | Yes |
| HY-10617A | Rucaparib | Inhibitor | 99.96% | Yes |
| HY-114778 | Fluzoparib | Inhibitor | 99.96% | Unkown |
| HY-10619A | Niraparib hydrochloride | Inhibitor | 99.41% | Yes |
| HY-10617 | Rucaparib phosphate | Inhibitor | 99.76% | Yes |
| HY-10619B | Niraparib tosylate | Inhibitor | 99.99% | Yes |
| HY-102003 | Rucaparib monocamsylate | Inhibitor | 99.91% | Yes |
| HY-113041 | Prostaglandin A2 | Activator | 99.9% | Unkown |
| HY-B0960 | Sulfabenzamide | 99.68% | Unkown | |
| HY-10619E | Niraparib tosylate hydrate | Inhibitor | 99.97% | Yes |
| HY-136489 | KU-0058948 | Inhibitor | 98.85% | Unkown |
| HY-10617C | Rucaparib tartrate | Inhibitor | / | Unkown |
| HY-102003A | Rucaparib camsylate | Inhibitor | / | Unkown |
| HY-10617D | Rucaparib acetate | Inhibitor | / | Unkown |
| HY-10617B | Rucaparib hydrochloride | Inhibitor | / | Unkown |
Clinical Phase
Bioactive Molecules
(13)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-122661 | Mefuparib hydrochloride | Inhibitor | 98.62% | Phase 4 |
| HY-132167 | Saruparib | Inhibitor | 99.76% | Phase 3 |
| HY-10129 | Veliparib | Inhibitor | 99.77% | Phase 3 |
| HY-12032 | AG14361 | Inhibitor | 99.42% | Phase 3 |
| HY-10130 | Veliparib dihydrochloride | Inhibitor | 99.98% | Phase 3 |
| HY-12015 | Iniparib | Inhibitor | 99.74% | Phase 3 |
| HY-12418 | Stenoparib | Inhibitor | 98.0% | Phase 2 |
| HY-137457A | Venadaparib hydrochloride | Inhibitor | / | Phase 2 |
| HY-105303 | CEP-9722 | Inhibitor | / | Phase 2 |
| HY-13536 | AZD-2461 | Inhibitor | 99.79% | Phase 1 |
| HY-13326 | ASP3026 | 99.88% | Phase 1 | |
| HY-115552 | Simmiparib | Inhibitor | 99.01% | Phase 1 |
| HY-170432 | PARP1-IN-34 | Inhibitor | / | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(155)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-15147 | XAV-939 | Inhibitor | 99.91% | Unkown |
| HY-13688A | PJ34 | Inhibitor | 99.66% | Unkown |
| HY-171006 | IRF1-IN-1 | Inhibitor | 99.72% | Unkown |
| HY-145471 | KSQ-4279 | Inhibitor | 99.96% | Unkown |
| HY-139156 | SK-575 | Inhibitor | 99.86% | Unkown |
| HY-N0213 | Peiminine | 99.89% | Unkown | |
| HY-171007 | IRF1-IN-2 | Inhibitor | 99.83% | Unkown |
| HY-N3584 | Paris saponin VII | Inhibitor | 99.84% | Unkown |
| HY-148566 | OUL232 | Inhibitor | 99.86% | Unkown |
| HY-14478 | UPF 1069 | Inhibitor | 99.02% | Unkown |
| HY-150207 | RBN-3143 | Inhibitor | 99.29% | Unkown |
| HY-13688 | PJ34 hydrochloride | Inhibitor | 99.81% | Unkown |
| HY-114869 | DPQ | Inhibitor | 99.68% | Unkown |
| HY-137457 | Venadaparib | Inhibitor | 98.11% | Unkown |
| HY-N6866 | Gomisin N | Activator | 99.94% | Unkown |
| HY-130644 | iRucaparib-AP6 | Degrader | 99.03% | Unkown |
| HY-123851 | MSC2504877 | Inhibitor | 99.25% | Unkown |
| HY-100225 | ME0328 | Inhibitor | 99.64% | Unkown |
| HY-75706 | N-Descyclopropanecarbaldehyde Olaparib | Inhibitor | 99.46% | Unkown |
| HY-12975 | AZ6102 | Inhibitor | 99.53% | Unkown |
| HY-19351 | MN-64 | Inhibitor | 99.61% | Unkown |
| HY-16106A | (8R,9S)-Talazoparib | Inhibitor | 98.28% | Unkown |
| HY-113352 | 7-Methylguanine | Inhibitor | 99.97% | Unkown |
| HY-170620 | PARP1 PROTAC 180055 | Inhibitor | 98.90% | Unkown |
| HY-117889 | PARP14 inhibitor H10 | Inhibitor | 99.46% | Unkown |
| HY-158045 | PROTAC PARP1 degrader-1 | Degrader | 99.86% | Unkown |
| HY-108632 | BYK204165 | Inhibitor | 99.89% | Unkown |
| HY-18954 | NMS-P118 | Inhibitor | 99.54% | Unkown |
| HY-10619D | Niraparib (R-enantiomer) | Inhibitor | 99.29% | Unkown |
| HY-114324 | PROTAC PARP1 degrader | Inhibitor | 99.74% | Unkown |
| HY-156419 | PARP7-IN-16 | Inhibitor | 99.91% | Unkown |
| HY-156419A | PARP7-IN-16 free base | Inhibitor | 99.40% | Unkown |
| HY-148754 | PARP10-IN-3 | Inhibitor | 98.72% | Unkown |
| HY-132297A | PARP1-IN-5 dihydrochloride | Inhibitor | 97.56% | Unkown |
| HY-10615 | A-620223 | Inhibitor | 98.84% | Unkown |
| HY-149800 | PARP-1-IN-3 | Inhibitor | 99.80% | Unkown |
| HY-145749 | PARPYnD | Inhibitor | 98.86% | Unkown |
| HY-10614 | A-966492 | Inhibitor | 99.00% | Unkown |
| HY-155993 | YCH1899 | Inhibitor | 99.39% | Unkown |
| HY-147886 | PARP1-IN-11 | Inhibitor | 99.42% | Unkown |
| HY-145471A | KSQ-4279 gentisate | Inhibitor | 99.75% | Unkown |
| HY-164926 | PARP1-IN-33 | Inhibitor | 99.02% | Unkown |
| HY-147027 | PARP-1-IN-2 | Inhibitor | 99.48% | Unkown |
| HY-148753 | PARP10-IN-2 | Inhibitor | 98.02% | Unkown |
| HY-15046 | EB-47 | Inhibitor | 99.89% | Unkown |
| HY-133124 | PARP/PI3K-IN-1 | Inhibitor | 99.40% | Unkown |
| HY-128599 | NMS-P515 | Inhibitor | 98.18% | Unkown |
| HY-182499 | PARP1-IN-56 | Inhibitor | 99.03% | Unkown |
| HY-105692 | DR2313 | Inhibitor | 99.66% | Unkown |
| HY-164475 | PARP1-IN-29 | Inhibitor | / | Unkown |
| HY-130646 | iVeliparib-AP6 | Degrader | / | Unkown |
| HY-160937 | AZD-9574-acid | Ligand | 99.44% | Unkown |
| HY-175885 | PROTAC FTO degrader 1 | Inducer | / | Unkown |
| HY-146548 | Anticancer agent 43 | Inducer | 98.58% | Unkown |
| HY-178496 | DDO3602 | Degrader | / | Unkown |
| HY-146336 | PARP1/2/TNKS1/2-IN-1 | Inhibitor | 98.66% | Unkown |
| HY-176713 | KWZY-11 | Inhibitor | / | Unkown |
| HY-123232 | KU-0058684 | Inhibitor | 98.54% | Unkown |
| HY-132297 | PARP1-IN-5 | Inhibitor | / | Unkown |
| HY-149001 | PARP1-IN-9 | Inhibitor | / | Unkown |
| HY-184277 | Tubulin/PARP1-IN-1 | Inhibitor | / | Unkown |
| HY-180809 | YCH3292 | Inhibitor | / | Unkown |
| HY-179685 | PARP1-IN-51 | Inhibitor | / | Unkown |
| HY-181068 | 2'-Nitroflavone | Inhibitor | / | Unkown |
| HY-178032 | PARP1-IN-44 | Inhibitor | / | Unkown |
| HY-146160 | PARP-1/HDAC-IN-1 | Inhibitor | / | Unkown |
| HY-147030 | PARP1-IN-8 | Inhibitor | 99.29% | Unkown |
| HY-163658 | PARP-1-IN-23 | Inhibitor | / | Unkown |
| HY-W973851 | 2H-Indazole-7-carboxamide | Degrader | / | Unkown |
| HY-181842 | PARP1/ERK IN-1 | Inhibitor | / | Unkown |
| HY-181746 | Bcl-2/Mcl-1-IN-5 | Activator | / | Unkown |
| HY-174836 | ZINC000081009201 | Inhibitor | / | Unkown |
| HY-181265 | PARP1-IN-53 | Inhibitor | / | Unkown |
| HY-168722 | PROTAC PARP1 degrader-3 | Degrader | / | Unkown |
| HY-132885 | PARP/EZH2-IN-1 | Inhibitor | / | Unkown |
| HY-161372 | PARP1/c-Met-IN-1 | Inhibitor | / | Unkown |
| HY-114943 | TNKS-IN-1 | Inhibitor | 99.55% | Unkown |
| HY-169299 | TOPOI/PARP-1-IN-2 | Inhibitor | / | Unkown |
| HY-161868 | DLC-50 | Inhibitor | / | Unkown |
| HY-158680 | PARP1-IN-21 | Inhibitor | / | Unkown |
| HY-178100 | PARP1-IN-45 | Inhibitor | / | Unkown |
| HY-162114 | PARP1-IN-18 | Inhibitor | / | Unkown |
| HY-147101 | SK-575-NEG | Inhibitor | / | Unkown |
| HY-178178 | PARP1-IN-46 | Inhibitor | / | Unkown |
| HY-167762 | TNKS-2-IN-4 | Inhibitor | / | Unkown |
| HY-181999 | PC8 | Inhibitor | / | Unkown |
| HY-155766 | PARP1-IN-14 | Inhibitor | / | Unkown |
| HY-150765 | PARP1-IN-12 | Inhibitor | / | Unkown |
| HY-136489A | KU-0058948 hydrochloride | Inhibitor | / | Unkown |
| HY-161606 | PARP-1/2/7-IN-1 | Inhibitor | / | Unkown |
| HY-183317 | IDO1-IN-34 | Activator | / | Unkown |
| HY-W294889 | OUL245 | Inhibitor | / | Unkown |
| HY-175471 | PARP1-IN-42 | Inhibitor | / | Unkown |
| HY-178468 | PARP1-IN-47 | Inhibitor | / | Unkown |
| HY-158334 | NDs-IN-1 | Inhibitor | / | Unkown |
| HY-181140 | UNPD139734 | Inhibitor | / | Unkown |
| HY-175482 | PARP1-IN-43 | Inhibitor | / | Unkown |
| HY-W424851 | DPQ hydrochloride | Inhibitor | / | Unkown |
| HY-169170 | PARP1/BRD4-IN-3 | Inhibitor | / | Unkown |
| HY-181720 | Antitumor agent-214 | Degrader | / | Unkown |
| HY-171543 | PARP1-IN-37 | Inhibitor | / | Unkown |
| HY-178348 | PARP1/c-Met-IN-2 | Inhibitor | / | Unkown |
| HY-148709 | ARTD10/PARP10-IN-1 | Inhibitor | / | Unkown |
| HY-163817 | PARP1/2-IN-3 | Inhibitor | / | Unkown |
| HY-182246 | MC2050 | Inhibitor | / | Unkown |
| HY-100847 | AZ0108 | Inhibitor | / | Unkown |
| HY-105253 | PARP-2/1-IN-2 | Inhibitor | / | Unkown |
| HY-150613 | PARP1/BRD4-IN-2 | Inhibitor | / | Unkown |
| HY-172224 | PARP1/CDK12-IN-1 | Inhibitor | / | Unkown |
| HY-181664 | YCH3971 | Inhibitor | / | Unkown |
| HY-181928 | PARP1/c-Met-IN-3 | Inhibitor | / | Unkown |
| HY-14687 | (rac)-Talazoparib | Inhibitor | / | Unkown |
| HY-181460 | PARP1 degrader-2 | Degrader | / | Unkown |
| HY-179020 | PARP/VEGFR3-IN-1 | Inhibitor | / | Unkown |
| HY-183373 | EGFR/PARP-1-IN-1 | Inhibitor | / | Unkown |
| HY-148710 | ARTD10/PARP10-IN-2 | Inhibitor | / | Unkown |
| HY-130645 | iRucaparib-TP3 | Degrader | / | Unkown |
| HY-184273 | TH-407a | Inhibitor | / | Unkown |
| HY-144338 | PARP1/BRD4-IN-1 | Inhibitor | / | Unkown |
| HY-168094 | PARP1-IN-30 | Inhibitor | / | Unkown |
| HY-181967 | PROTAC PARP1 degrader-5 | Degrader | / | Unkown |
| HY-176128 | BWA-6047 | / | Unkown | |
| HY-168851 | PARP1-IN-35 | Inhibitor | / | Unkown |
| HY-183143 | Lss-11 | Activator | / | Unkown |
| HY-179386 | PARP1/EZH2-IN-1 | Inhibitor | / | Unkown |
| HY-175175 | MAPK-IN-5 | Inhibitor | / | Unkown |
| HY-129599 | L-2286 | Inhibitor | / | Unkown |
| HY-181459 | PARP1-IN-55 | Inhibitor | / | Unkown |
| HY-174828 | ATR/PARP1-IN-1 | Inhibitor | / | Unkown |
| HY-178972 | PARP1-IN-48 | Inhibitor | / | Unkown |
| HY-172747 | TNKS-2-IN-3 | Inhibitor | / | Unkown |
| HY-149003 | PARP1-IN-10 | Inhibitor | / | Unkown |
| HY-130647 | Vrucaparib-TP4 | Degrader | / | Unkown |
| HY-181158 | PARP1-IN-52 | Inhibitor | / | Unkown |
| HY-183765 | PARP1/PKM2-IN-1 | Inhibitor | / | Unkown |
| HY-158681 | PARP1-IN-22 | Inhibitor | / | Unkown |
| HY-179349 | PARP-1/2-IN-5 | Inhibitor | / | Unkown |
| HY-179614 | PARP1-IN-50 | Inhibitor | / | Unkown |
| HY-180276 | PARP1 degrader 1 | Degrader | / | Unkown |
| HY-173597 | ZINC43120769 | Inhibitor | / | Unkown |
| HY-157137 | PARP1-IN-17 | / | Unkown | |
| HY-179406 | PARP1-IN-49 | Inhibitor | / | Unkown |
| HY-161517 | PARP1-IN-20 | Inhibitor | / | Unkown |
| HY-182269 | Cathepsin-IN-5 | / | Unkown | |
| HY-175466 | BER-IN-1 | Inhibitor | / | Unkown |
| HY-N17653 | 13'-Carboxy-δ-tocopherol | / | Unkown | |
| HY-161083 | PARP/EZH2-IN-2 | Inhibitor | / | Unkown |
| HY-170942 | CDK9/PARP-IN-1 | Inhibitor | / | Unkown |
| HY-181254 | PARP1/NAMPT-IN-1 | Inhibitor | / | Unkown |
| HY-117423 | ST7710AA1 | Inhibitor | / | Unkown |
| HY-108238 | BSI-401 | Inhibitor | / | Unkown |
| HY-132157 | 8-Chloroquinazolin-4-ol | Inhibitor | 98.44% | Unkown |
| HY-115862 | Benzo[c][1,8]naphthyridin-6(5H)-one | Inhibitor | / | Unkown |
| HY-14477 | UPF-1035 | Inhibitor | / | Unkown |
| HY-U00223 | WD2000-012547 | Inhibitor | / | Unkown |
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Homo sapiens | PARP1 | NCBI | NCBI:142 |
| Mus musculus | PARP1 | NCBI | NCBI:11545 |